Internal Medicine, Hematology & Oncology · Saint Louis, MO
NPI
1164577300
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
607 S New Ballas Rd, Suite 3300
Saint Louis, MO, 63141
Phone (314) 251-4400
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
1,455 services
Medicare patients, 2024
559
Average age 73
Drug cost, 2024
$8.4M
3,331 prescriptions
Company payments, 2025
$1,372
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heide A Rodgers was code 99214 (office e&m - established), 472 times for 297 patients. In total Heide A Rodgers billed 1,455 services in 14 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 472 | 297 | $68.52 | $32K |
| 99215 Office E&M - Established | Facility | 226 | 123 | $93.62 | $21K |
| 99213 Office E&M - Established | Facility | 219 | 168 | $46.95 | $10K |
| 99214 Office E&M - Established | Office | 202 | 163 | $56.52 | $11K |
| 99215 Office E&M - Established | Office | 103 | 67 | $113.62 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 71 | 63 | $11.98 | $850 |
| 99213 Office E&M - Established | Office | 63 | 59 | $42.12 | $2,654 |
| 99223 Hospital E&M - Initial | Facility | 30 | 27 | $131.94 | $3,958 |
| 99204 Office E&M - New | Facility | 15 | 15 | $83.37 | $1,251 |
| 99205 Office E&M - New | Facility | 11 | 11 | $133.28 | $1,466 |
By year: 2022 $142K for 1,483 services; 2023 $150K for 1,561 services; 2024 $101K for 1,455 services.
Medicare prescription drug claims, 2024
In 2024, the drug Heide A Rodgers prescribed most often to Medicare patients was Anastrozole, with 465 prescriptions and refills. In total Heide A Rodgers wrote 3,331 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 465 | 1,255 | 136 | $7,193 |
| Letrozole Generic | 245 | 620 | 62 | $6,039 |
| Eliquis Apixaban | 138 | 171 | 22 | $100K |
| Imbruvica Ibrutinib | 127 | 127 | 11 | $1.7M |
| Ibrance Palbociclib | 110 | 110 | 11 | $1.7M |
| Pantoprazole Sodium Generic | 108 | 266 | 38 | $1,455 |
| Tamoxifen Citrate Generic | 103 | 278 | 30 | $1,873 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 67 | 166 | 18 | $917 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 63 | 63 | 21 | $2,097 |
| Gabapentin Generic | 62 | 89 | 21 | $638 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 60 | 60 | 18 | $1,932 |
| Revlimid Lenalidomide | 56 | 56 | Under 11 | $1.2M |
| Hydroxyurea Generic | 56 | 132 | 16 | $1,348 |
| Escitalopram Oxalate Generic | 55 | 69 | Under 11 | $240 |
| Jakafi Ruxolitinib Phosphate | 50 | 50 | Under 11 | $745K |
Brand drugs: 828 claims; generic drugs: 2,503 claims; opioid claims: 202.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heide A Rodgers $1,372 ($1,372 in general payments such as food, travel and fees) from 34 companies. The largest payer was Adc Therapeutics America, Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Adc Therapeutics America, Inc. | 1 | $180 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $141 |
| GT Medical Technologies, Inc | 3 | $86.58 |
| Merck Sharp & Dohme LLC MRK | 3 | $76.48 |
| GlaxoSmithKline, LLC. GSK | 3 | $74.05 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $61 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $56.39 |
| Daiichi Sankyo Inc. 4568.T | 2 | $54.12 |
| Astellas Pharma US Inc 4503.T | 2 | $44.45 |
| Janssen Biotech, Inc. JNJ | 2 | $40.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.